Abstract
African swine fever (ASF) is one of the most severe diseases caused by the ASF virus (ASFV), causing massive economic losses to the global pig industry. Serological tests are important in ASF epidemiological surveillance, and more antigen targets are needed to meet market demand for ASFV antibody detection. In the present study, ASFV p15 protein was fusion-expressed in Escherichia coli (E. coli) with elastin-like polypeptide (ELP), and the ELP-p15 protein was purified using a simple inverse transition cycling (ITC) process. The ELP tag was cleaved off using tobacco etch virus protease (TEVp), resulting in a tag-free p15 protein. Western blot analysis demonstrated that the p15 protein reacted strongly with ASFV-positive serum. The p15 protein was used as a coating antigen in an indirect ELISA (iELISA) for detecting ASFV antibodies. The p15-iELISA method demonstrated high specificity to ASFV-positive sera, with a maximum detection dilution of 1:1600. Moreover, the method exhibited good reproducibility, with less intra-assay and inter-assay CV values than 10%. Therefore, p15-iELISA offers a novel approach for accurately detecting ASFV antibodies with significant clinical application potential.
Keywords:
African swine fever virus; indirect ELISA; p15 protein; tag-free antigen.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
African Swine Fever Virus*
-
African Swine Fever* / diagnosis
-
Animals
-
Antibodies
-
Enzyme-Linked Immunosorbent Assay
-
Escherichia coli / genetics
-
Reproducibility of Results
-
Swine
Grants and funding
This research was funded by the Science and Technology Support Program (Agriculture) of Taizhou City (Grant No. TN202001), National Natural Science Foundation of China (Grant No. 31902303), National Natural Science Foundation of China (Grant No. 32272995), Jiangsu Provincial Research Foundation for Basic Research of China (Grant No. BK20201063), Key Research and Development Program (Modern Agriculture) of Jiangsu Province (Grant No. BE2020407), Jiangsu Provincial Science and Technology Plan Special Fund (Basic Research Plan Natural Science Foundation) General Project (2023-205), Qing Lan Project of Jiangsu Provincial University (2023), Outstanding Science and Technology Innovation Team Project of Jiangsu Provincial University (2023-35), High-Value Invention Patent Technology Team Cultivation Fund of Yancheng Teachers University (306124027), Startup Fund for Scientific Research of Yancheng Teachers University (No. 204120019 and 204120020), Opening Project of Jiangsu Province Engineering Research Center of Tumor Targeted Nano Diagnostic and Therapeutic Materials (JETNM202207), and Fund of Zhengzhou Dabai Biotechnology Co., Ltd. (No. 203120066).